Clinical Trials on Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Total 2057 results

King Abdullah International Medical Research Center

Completed

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b (MIRACLE)

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Saudi Arabia
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Lebanon, Jordan, Kenya
Gamaleya Research Institute of Epidemiology and...

Unknown

Study of Safety and Immunogenicity of BVRS-GamVac

MERS (Middle East Respiratory Syndrome) | MERS

Russian Federation
Marylyn Addo
Charite University, Berlin, Germany; University of Cologne; Ludwig-Maximilians... and other collaborators

Completed

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

MERS (Middle East Respiratory Syndrome)

Germany
Gamaleya Research Institute of Epidemiology and...
Acellena Contract Drug Research and Development

Recruiting

Study of Safety and Immunogenicity of BVRS-GamVac-Combi

MERS (Middle East Respiratory Syndrome) | MERS

Russian Federation
Universitätsklinikum Hamburg-Eppendorf
Erasmus Medical Center; German Center for Infection Research; Coalition for Epidemic... and other collaborators

Active, not recruiting

Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS (MVA-MERS-S)

MERS (Middle East Respiratory Syndrome)

Germany, Netherlands
University of Oxford

Terminated

Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)

MERS (Middle East Respiratory Syndrome)

United Kingdom
King Abdullah International Medical Research Center
University of Oxford

Completed

A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)

Middle East Respiratory Syndrome Coronavirus

Saudi Arabia
National Institute of Allergy and Infectious Diseases...
Naval Medical Research Center; SAb Biotherapeutics, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults

Middle East Respiratory Syndrome Coronavirus

United States
National Research Centre, Egypt
Egyptian Military Medical Services

Not yet recruiting

Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease (COVID-19_LF)

COVID-19 | Coronavirus Infection | SARS-CoV 2 | Acute Respiratory Distress Syndrome | Corona Virus Infection | Middle East Respiratory Syndrome (MERS)

Egypt
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Recruiting

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Influenza | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

United States, Australia, Spain, Denmark, Greece, Argentina, United Kingdom, Belgium, Chile, Germany, Peru, Thailand
Imam Abdulrahman Bin Faisal University
King Abdulaziz University; Ministry of Health, Saudi Arabia

Completed

Saudi Outcomes of ECMO-treated MERS-CoV Patients

Refractory Hypoxemia | MERS-CoV Infection

Saudi Arabia
Patricia Schlagenhauf
University Hospital, Geneva; Swiss Tropical & Public Health Institute; ETH Zurich and other collaborators

Not yet recruiting

Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria (ITIT)

Diarrhea | Malaria | Influenza | SARS-CoV Infection | Dengue | Chikungunya | Zika | Travel-Related Illness | MERS

Switzerland
University Hospital, Basel, Switzerland

Completed

Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 (COVID-RT-01)

Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)

Switzerland
Rennes University Hospital

Unknown

Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 (ECMO-SARS)

ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2 | Acute Refractory Heart Failure Related to SARS-CoV 2

France
Saint Francis Care

Completed

Convalescent Plasma in the Treatment of COVID 19

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | COVID | Coronavirus

United States
National Institute of Allergy and Infectious Diseases...
Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)

Completed

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations (SARS)

COVID-19 | SARS-CoV Infection | Allergic Reaction | Mast Cell Disorder

United States
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Fort Worth Clinical Sciences Working Group
TCU and UNTHSC School of Medicine

Not yet recruiting

Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients (FWCSWG-IL-2)

SARS-CoV2 Infection | Cytokine Storm | SARS-CoV-2 Acute Respiratory Disease
Leidos Life Sciences
United States Department of Defense

Active, not recruiting

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
AbbVie

Completed

A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois (CONTACT)

Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)

United States
Leidos Life Sciences
United States Department of Defense

Withdrawn

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection
Imam Abdulrahman Bin Faisal University
Dammam Medical Complex; Institute for Research and medical consultations (IRMC)

Unknown

Antibodies Responses to COVID-19 Infection in Hospitalized Patients (No-SARS)

Hospitalized Patients | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection) | Laboratory-confirmed SARS-CoV 2 Infection

Saudi Arabia
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Recruiting

Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection (COVERAGE-A)

Covid19 | SARS-CoV2 Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Covid19 Drug Treatment

Burkina Faso, Guinea
Goethe University
Nationwide Network of University Medicine (NUM) on Covid-19

Recruiting

Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON) (SUEP-NAPKON)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Germany
Gérond'if

Completed

Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization (COVINUT)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

France
ANRS, Emerging Infectious Diseases

Recruiting

Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection (SEVASAR)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

France, Martinique
University of Pecs
Hungarian Ministry of Innovation and Technology

Terminated

Study to Assess the Efficacy and Safety of Favipiravir-HU

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Hungary
Grifols Therapeutics LLC

Terminated

A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients (COVID-19)

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Spain
AUVA
Paracelsus Medical University

Completed

Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.

Coronavirus Infection | SARS-CoV 2 | Covid19 | Severe Acute Respiratory Syndrome Coronavirus 2

Austria
Cogna Technology Solutions LLC
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

United Arab Emirates
Inovio Pharmaceuticals
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.

Terminated

Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Infection | COVID-19 Disease

United States, Mexico, Colombia
National Institute of Allergy and Infectious Diseases...
PPD; University of Washington; Vanderbilt University Medical Center; Implicit Bioscience

Terminated

COVID-19 and Anti-CD14 Treatment Trial (CaTT)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19)

United States
ProgenaBiome
Topelia Therapeutics

Active, not recruiting

Trial of Combination Therapy to Treat COVID-19 Infection

Coronavirus Infection | Covid-19 | COVID | Corona Virus Infection | SARS-CoV Infection | SARS-CoV2 | Coronavirus-19

United States
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence; Clinical Trials in Organ Transplantation...

Completed

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C (PRISM)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Multisystem Inflammatory Syndrome in Children (MIS-C)

United States
University College, London
University College London Hospitals; The Leeds Teaching Hospitals NHS Trust; Nottingham... and other collaborators

Unknown

COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study (COV-HI)

COVID-19 | COV-HI | COVID-19 (COV) Hyperinflammatory (HI) Syndrome

United Kingdom
BioNTech SE
Pfizer

Recruiting

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 Virus

United States, South Africa, Brazil, Puerto Rico
Hospices Civils de Lyon

Completed

Host-pathogen Interactions During SARS-CoV-2 Infection (HPI-COVID-19)

Severe Acute Respiratory Syndrome Coronavirus 2 | Infection, Coronavirus

France
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
University of Pecs

Terminated

Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary (PROACTIVE-19)

COVID-19 | SARS-CoV-2 | Coronavirus | 2019-nCoV | 2019nCoV

Hungary
Takeda

Completed

A Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

Japan
Hôpital Universitaire Sahloul

Completed

The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) (Quercetix)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | a Randomized Double-blind Study | PHYTOTHERAPIE

Tunisia
Vanderson Geraldo Rocha

Terminated

Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 (RUXO-COVID)

SARS-CoV2 | Severe Acute Respiratory Syndrome Coronavirus 2

Brazil
Tuberculosis Research Centre, India
National Institutes of Health (NIH)

Recruiting

MISC COVID-19 Study in Pediatric Population (COVID-19)

SARS-CoV2 Infection | Multisystem Inflammatory Syndrome in Children

India
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
Pfizer

Withdrawn

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19 (EPIC-HOS)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Immunocompromised | Hospitalization | Child, Hospitalized

United States, Bulgaria
University Hospital of Ferrara

Active, not recruiting

Pro-thrombotic Status in Patients With SARS-Cov-2 Infection (ATTAC-Co)

Severe Acute Respiratory Syndrome Coronavirus 2

Italy
Rohto Pharmaceutical Co., Ltd.

Completed

An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)

Severe Acute Respiratory Syndrome Coronavirus 2

Japan
Azienda Ospedaliera Universitaria Integrata Verona
Charite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaborators

Recruiting

Follow-up of Covid-19 Long Term Sequelae

Coronavirus Infections | Covid19 | Coronavirus Disease 2019 | Corona Virus Infection | Coronavirus | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | SARS (Severe Acute Respiratory Syndrome) | COVID-19 Respiratory Infection | SARS (Disease) | COVID-19 Acute Respiratory Distress... and other conditions

Italy, Belgium, Congo, France, Netherlands, Spain
Collegium Medicum w Bydgoszczy

Recruiting

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation (DANTE-SIRIO 8)

SARS-CoV2 Infection | SARS-CoV2 Antibodies

Poland

Clinical Trials on Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations